Search Results - "Garcia, Miriam B."
-
1
Comprehensive characterization of IFNγ signaling in acute myeloid leukemia reveals prognostic and therapeutic strategies
Published in Nature communications (28-02-2024)“…Interferon gamma (IFNγ) is a critical cytokine known for its diverse roles in immune regulation, inflammation, and tumor surveillance. However, while…”
Get full text
Journal Article -
2
Case series: Stenotrophomonas maltophilia in pediatric oncology patients
Published in Cancer reports (01-03-2024)“…Background Stenotrophomonas maltophilia is a bacterial pathogen that can be fatal in hospitalized and immunocompromised patients with mortality as high as 69%…”
Get full text
Journal Article -
3
Successful first‐line treatment of hemophagocytic lymphohistiocytosis with ruxolitinib in a pediatric patient with trisomy 21
Published in Pediatric blood & cancer (01-06-2023)Get full text
Journal Article -
4
Novel immunotherapeutic approaches for pediatric classical Hodgkin lymphoma: Nivolumab or brentuximab vedotin with the AVD regimen
Published in Pediatric blood & cancer (01-08-2024)Get full text
Journal Article -
5
Nutritional intervention as adjuvant therapy for T-cell acute lymphoblastic leukemia
Published in Blood advances (22-10-2024)Get full text
Journal Article -
6
Exercise and Physical Activity in Patients with Osteosarcoma and Survivors
Published in Advances in experimental medicine and biology (2020)“…Exercise has the potential to positively affect patients with osteosarcoma by improvement of function, mitigation of disability, and maintenance of…”
Get more information
Journal Article -
7
Venetoclax use in a patient with ataxia telangiectasia and early T‐cell precursor acute lymphoblastic leukemia
Published in Pediatric blood & cancer (01-08-2024)Get full text
Journal Article -
8
-
9
Frontline Hyper-CVAD Plus Venetoclax for Pediatric Blastic Plasmacytoid Dendritic Cell Neoplasm
Published in Journal of pediatric hematology/oncology (01-11-2023)“…Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematologic malignancy, especially in pediatrics, that can involve the bone marrow, skin, lymph…”
Get full text
Journal Article -
10
Translating energy balance research from the bench to the clinic to the community: Parallel animal‐human studies in cancer
Published in CA: a cancer journal for clinicians (01-07-2023)“…Advances in energy balance and cancer research to date have largely occurred in siloed work in rodents or patients. However, substantial benefit can be derived…”
Get full text
Journal Article -
11
KIT‐mutated pediatric core‐binding factor systemic mastocytosis‐acute myeloid leukemia treated with avapritinib and decitabine
Published in Pediatric blood & cancer (01-04-2024)Get full text
Journal Article -
12
Pharmacokinetics of cancer therapeutics and energy balance: the role of diet intake, energy expenditure, and body composition
Published in Journal of the National Cancer Institute. Monographs (04-05-2023)“…Energy balance accounts for an individual's energy intake, expenditure, and storage. Each aspect of energy balance has implications for the pharmacokinetics of…”
Get full text
Journal Article -
13
Observation and Management of Juvenile Myelomonocytic Leukemia and Noonan Syndrome-Associated Myeloproliferative Disorder: A Real-World Experience
Published in Cancers (02-08-2024)“…Juvenile Myelomonocytic Leukemia (JMML) is a rare and clonal hematopoietic disorder of infancy and early childhood with myeloproliferative/myelodysplastic…”
Get full text
Journal Article -
14
Biological Markers of High-Risk Childhood Acute Lymphoblastic Leukemia
Published in Cancers (21-02-2024)“…Childhood acute lymphoblastic leukemia (ALL) has witnessed substantial improvements in prognosis; however, a subset of patients classified as high-risk…”
Get full text
Journal Article -
15
Frontline Venetoclax Therapy for 18-Year-Old Male with Ataxia Telangiectasia and Early T-Cell Precursor Acute Lymphoblastic Leukemia
Published in Blood (02-11-2023)“…Ataxia Telangiectasia (AT) is an autosomal recessive disorder which is associated with progressive neurodegeneration, immunodeficiency, and predisposition to…”
Get full text
Journal Article -
16
Targeted Protein Degradation for c-MYC Overcomes Therapy Resistance in T-Cell Acute Lymphoblastic Leukemias
Published in Blood (02-11-2023)“…T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive hematological malignancy characterized by diffuse infiltration of the bone marrow by immature…”
Get full text
Journal Article -
17
IFNγ Signaling in Acute Myeloid Leukemia Mediates Immunomodulation and Reveals Therapeutic Strategies
Published in Blood (02-11-2023)“…Background: Interferon gamma (IFNγ) is a critical cytokine known for its diverse roles in immune regulation, inflammation, and tumor surveillance. Studies have…”
Get full text
Journal Article -
18
Early Results of the Phase I/II Study Investigating the All-Oral Combination of the Menin Inhibitor Revumenib (SNDX-5613) with Decitabine/Cedazuridine (ASTX727) and Venetoclax in Acute Myeloid Leukemia (SAVE)
Published in Blood (02-11-2023)“…Background: The interaction of menin with lysine methyltransferase 2A (KMT2A) is a dependency in acute leukemia caused by either rearrangement of the KMT2A…”
Get full text
Journal Article -
19
Case series: Stenotrophomonas maltophilia in pediatric oncology patients
Published in Cancer reports (Hoboken, N.J.) (01-03-2024)“…BACKGROUNDStenotrophomonas maltophilia is a bacterial pathogen that can be fatal in hospitalized and immunocompromised patients with mortality as high as 69%…”
Get full text
Report -
20